Dyne Therapeutics (DYN) Assets Average (2020 - 2026)

Dyne Therapeutics' Assets Average history runs 7 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Assets Average rose 60.51% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 60.51% YoY), while the FY2025 annual figure was $939.1 million, up 119.33% from the prior year.
• Assets Average was $1.1 billion for Q1 2026 at Dyne Therapeutics, up from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2026 to a low of $185.2 million in Q4 2023.
• Historically, Assets Average has averaged $547.6 million across 5 years, with a median of $406.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets Average slumped 38.89% in 2023, then surged 294.27% in 2024.
• A 5-year view of Assets Average shows it stood at $303.0 million in 2022, then plunged by 38.89% to $185.2 million in 2023, then soared by 294.27% to $730.0 million in 2024, then jumped by 40.68% to $1.0 billion in 2025, then climbed by 10.36% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.0 billion (Q4 2025), and $798.0 million (Q3 2025), per Business Quant data.